Reproduction/Androgen Disorders News

The FDA added a boxed warning to highlight known risk for rare but serious liver injury associated with the use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, according to an agency press release.

Compared with a low-fat diet, nutritional ketosis with or without exogenous ketones may positively impact self-reported menses for women, restarting or realigning menstrual cycles, according to study results published in PLOS ONE.

Women are living, on average, 5 years longer than men with an improved overall quality of life, but with an increased lifespan comes greater risk for multimorbidity, particularly after the menopause transition.

Short-term exposure to hormone therapy started within 3 years of menopause was not associated with long-term cognitive impairment or benefit, according to data from the KEEPS Continuation study.

Men with lower concentrations of sex hormone-binding globulin may be less likely to sustain a fracture than those with higher levels, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Later age at natural menopause may be a risk factor for asthma, potentially due to prolonged estrogen exposure, data from a longitudinal study show.

Women with polycystic ovary syndrome who initiated any weight-loss intervention saw improvements in some glycemic and hormonal measures as well as improved menstrual frequency, data from a meta-analysis show.

Women with frequent and persistent hot flashes and night sweats during the menopause transition are at increased risk for developing diabetes compared with women who do not experience vasomotor symptoms, researchers reported.

Women with vs. without polycystic ovary syndrome have a higher risk for emotional and uncontrolled eating behaviors at midlife, with contrasts observed among different phenotypes, according to findings published in Fertility and Sterility.